Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytidine Deaminase | 6 | 2024 | 249 | 1.710 |
Why?
|
| Uracil | 3 | 2024 | 210 | 0.820 |
Why?
|
| Cytosine | 4 | 2024 | 213 | 0.590 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 1478 | 0.460 |
Why?
|
| Proteins | 4 | 2024 | 6009 | 0.400 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 4620 | 0.370 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4786 | 0.300 |
Why?
|
| Minor Histocompatibility Antigens | 3 | 2024 | 303 | 0.270 |
Why?
|
| DNA | 4 | 2024 | 7213 | 0.220 |
Why?
|
| Genomics | 1 | 2019 | 5926 | 0.210 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 103 | 0.190 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2022 | 289 | 0.180 |
Why?
|
| Lactams | 1 | 2021 | 159 | 0.170 |
Why?
|
| Escherichia coli | 3 | 2022 | 4213 | 0.170 |
Why?
|
| Nucleic Acid Conformation | 1 | 2021 | 901 | 0.140 |
Why?
|
| Aminopyridines | 1 | 2021 | 580 | 0.140 |
Why?
|
| Amines | 1 | 2017 | 280 | 0.130 |
Why?
|
| Substrate Specificity | 1 | 2019 | 1751 | 0.120 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 1613 | 0.100 |
Why?
|
| Base Sequence | 2 | 2021 | 12422 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 2433 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2021 | 2846 | 0.090 |
Why?
|
| Pyrazoles | 1 | 2021 | 2028 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2023 | 5341 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 4528 | 0.080 |
Why?
|
| Mutation | 6 | 2024 | 30237 | 0.080 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 13586 | 0.070 |
Why?
|
| Neoplasms | 3 | 2024 | 22371 | 0.070 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2023 | 606 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 7609 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 4793 | 0.060 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2021 | 318 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2021 | 4280 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2023 | 716 | 0.040 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2017 | 72 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2021 | 1228 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2021 | 1441 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 1743 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 3056 | 0.030 |
Why?
|
| Humans | 8 | 2024 | 768171 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 17142 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2023 | 2830 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2017 | 3074 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2021 | 5402 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2017 | 945 | 0.020 |
Why?
|
| Alleles | 1 | 2021 | 6894 | 0.020 |
Why?
|
| Biopsy | 1 | 2021 | 6792 | 0.020 |
Why?
|
| DNA Repair | 1 | 2017 | 2050 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5789 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 5704 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2017 | 19025 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 59626 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 13677 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 60066 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 171502 | 0.000 |
Why?
|
| Middle Aged | 1 | 2021 | 223487 | 0.000 |
Why?
|
| Adult | 1 | 2021 | 223646 | 0.000 |
Why?
|
| Male | 1 | 2021 | 364731 | 0.000 |
Why?
|
| Female | 1 | 2021 | 397187 | 0.000 |
Why?
|
Concepts
(59)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_